Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery
Clinical trial NCT04294277 · TERMINATED
Trial details
- NCT number
- NCT04294277
- Sponsor
- European Association of Urology Research Foundation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2021-11-15
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.